Candid Therapeutics Raises $370M to Advance T-Cell Engager Drugs for Autoimmune Diseases
Candid Therapeutics, a San Diego-based biotechnology company, has secured $370 million in funding to accelerate the development of its innovative ...
Candid Therapeutics, a San Diego-based biotechnology company, has secured $370 million in funding to accelerate the development of its innovative ...
At the recently held USTechTimes Global Launchpad event, Nishant Bhaskar, founder of Nereal and former creator of Lomads, provided essential ...
HomeLight, the real estate technology platform revolutionizing home transactions, has secured $20 million in new funding to accelerate the expansion ...
San Mateo-based Kiteworks Inc., a secure content communications startup, has raised $456 million to leverage its Private Content Network to ...
Rhombus has secured $45 million in Series C funding from NightDragon, boosting its leadership in cloud-managed physical security with innovative ...
Astranis, a San Francisco-based geostationary satellite maker, has raised $200 million in Series D funding led by Andreessen Horowitz (a16z) ...
In a recent interview with USTechTimes, Vivek Anand, Director of Data Science at a Fortune 500 retailer, shared valuable insights ...
Amplify Life Insurance has secured $20 million in Series B funding to revolutionize the permanent life insurance industry by offering ...
Lamini, a startup specializing in artificial intelligence (AI) technology, has raised $25 million from leading tech investors, including AMD, marking ...
GroundGame.Health, a Tampa-based company merged with SameSky Health and raised $17 million in a funding round led by 7wireVentures to ...
© 2023 ustechtimes.com